Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES
Clinical trial NCT03433248 · UNKNOWN
Trial details
- NCT number
- NCT03433248
- Sponsor
- M.H.H. Kramer
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2021-06-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.